These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34564896)

  • 1. Baseline lncRNA PCAT1 high expression and its longitude increment during induction therapy predict worse prognosis in multiple myeloma patients.
    Zhao P; Zhao X
    J Clin Lab Anal; 2021 Nov; 35(11):e23924. PubMed ID: 34564896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA T-cell factor 7 in multiple myeloma: A potential biomarker for deteriorated clinical features and poor prognosis.
    Zhang C; Chu M; Fan Y; Wu L; Li Z; Ma X; Zhuang W
    J Clin Lab Anal; 2020 Sep; 34(9):e23400. PubMed ID: 32578294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
    Zhou F; Guo L
    Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
    Yu H; Peng S; Chen X; Han S; Luo J
    J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
    Gao W
    Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHD finger protein 19 expression in multiple myeloma: Association with clinical features, induction therapy outcome, disease progression, and survival.
    Li Y; Gong J; Zhang L
    J Clin Lab Anal; 2021 Sep; 35(9):e23910. PubMed ID: 34390275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
    Yin Y; Yang W; Zhang L; Liu K; Luo Z
    Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated lncRNA-PCAT1 is closely related to clinical diagnosis of multiple myeloma as a predictive biomarker in serum.
    Shen X; Zhang Y; Wu X; Guo Y; Shi W; Qi J; Cong H; Wang X; Wu X; Ju S
    Cancer Biomark; 2017; 18(3):257-263. PubMed ID: 28085010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation of long non-coding RNA intersectin 1-2 with disease risk, disease severity, inflammation, and prognosis of acute ischemic stroke.
    Zhang Y; Niu C
    J Clin Lab Anal; 2020 Feb; 34(2):e23053. PubMed ID: 31647141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression pattern of PCAT1, PCAT2, and PCAT5 lncRNAs and their value as diagnostic biomarkers in patients with gastric cancer.
    Akhgari H; Shokri N; Dehghanzadeh P; Tayefeh-Gholami S; Rajabi A; Safaralizadeh R
    Pathol Res Pract; 2023 Aug; 248():154654. PubMed ID: 37392552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the plasma level of long non-coding RNA PCAT1 in prostatic hyperplasia and newly diagnosed prostate cancer patients.
    Rezatabar S; Moudi E; Sadeghi F; Khafri S; Kopi TA; Parsian H
    J Gene Med; 2020 Oct; 22(10):e3239. PubMed ID: 32529802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of A-Kinase Interacting Protein 1 With Clinical Features, Treatment Response, and Survival Profiles in Patients With Multiple Myeloma.
    Wang W; Xie Y; Han X; Liu Y; Li P
    Technol Cancer Res Treat; 2020; 19():1533033820935856. PubMed ID: 32799782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
    Bao Y; Wei M; Ji X
    J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of multiple myeloma with de novo del(17p).
    Lakshman A; Painuly U; Rajkumar SV; Ketterling RP; Kapoor P; Greipp PT; Gertz MA; Buadi FK; Lacy MQ; Dingli D; Dispenzieri A; Fonder AL; Hayman SR; Hobbs MA; Gonsalves WI; Hwa YL; Leung N; Go RS; Lin Y; Kourelis TV; Warsame R; Lust JA; Russell SJ; Zeldenrust SR; Kyle RA; Kumar SK
    Blood Cancer J; 2019 Mar; 9(3):32. PubMed ID: 30846679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
    Cho SF; Chang YC; Chang CS; Lin SF; Liu YC; Hsiao HH; Chang JG; Liu TC
    BMC Cancer; 2014 Nov; 14():809. PubMed ID: 25369863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction: The
    Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
    Turk J Haematol; 2022 Aug; 39(3):188-195. PubMed ID: 35657175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNP rs710886 A>G in long noncoding RNA PCAT1 is associated with the risk of endometriosis by modulating expression of multiple stemness-related genes via microRNA-145 signaling pathway.
    Wang L; Xing Q; Feng T; He M; Yu W; Chen H
    J Cell Biochem; 2020 Feb; 121(2):1703-1715. PubMed ID: 31595574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of Relationship between Long Non-Coding RNA Small Nucleolar RNA Host Gene 1 and Acute Myeloid Leukemia Risk and Prognosis in Pediatric Patients].
    Su W; Hong Y; Jiang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1127-1136. PubMed ID: 32798387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Kinase D 1 Predicts Poor Treatment Response and Unfavorable Survival of Bortezomib-Based Treatment, and Its Knockdown Enhances Drug Sensitivity to Bortezomib in Multiple Myeloma.
    Li X; Yang Y; Yi X
    Technol Cancer Res Treat; 2020; 19():1533033820936770. PubMed ID: 32799769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
    Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
    Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.